-
At Last, Merck Is Diving Into Coronavirus Vaccine and Antiviral Development
Post on 5/27/20
-
States with the Best Health Infrastructure for Coronavirus – WalletHub Study
Post on 5/26/20
-
Better Buy: AbbVie vs. Merck
Post on 5/26/20
-
Bellerophon Therapeutics Closes $43.7M Public Offering of Common Stock
Post on 5/25/20
-
Oyster Point Pharma Closes Public Offering of Common Stock
Post on 5/25/20
-
Windtree Therapeutics Closes $23M Public Offering
Post on 5/24/20
-
Bellerophon Therapeutics Announces Proposed Public Offering of Common Stock
Post on 5/21/20
-
Krystal Biotech Announces Proposed Public Offering of Common Stock
Post on 5/21/20
-
Suburban Propane Partners with Jersey Mike’s Subs and RWJ University Hospital
Post on 5/21/20
-
Better Buy: GlaxoSmithKline vs. Pfizer
Post on 5/21/20
-
Johnson & Johnson Plans to Stop Selling Talc-Based Baby Powder
Post on 5/21/20
-
Pfizer Participates in Funding for Biotech Startup Amplyx
Post on 5/21/20
-
Windtree Therapeutics Prices $20M Public Offering
Post on 5/20/20
-
GlaxoSmithKline, Pfizer, and Shionogi's HIV Prevention Candidate Outperforms Gilead's Truvada
Post on 5/20/20
-
Johnson & Johnson's Oncology Team Posts Promising Cancer Trial Results
Post on 5/20/20
-
AmerisourceBergen Closes $500M Senior Note Offering
Post on 5/19/20
-
PANTHERx Rare Pharmacy Recognized as a US Best Managed Company
Post on 5/19/20
-
Enzychem Lifesciences Appoints Dr. Cameron Wolfe to Lead Development of EC-18 as a COVID-19 Therapeutic Drug
Post on 5/18/20
-
Citius Closes $7.5M Registered Direct Offering
Post on 5/18/20
-
Quest Diagnostics Incorporated: A Leader In Diagnostic Information Services
Post on 5/18/20
-
Better Coronavirus Stock: Johnson & Johnson or Emergent BioSolutions?
Post on 5/18/20
-
Better Buy: Pfizer vs. Bristol Myers Squibb
Post on 5/18/20
-
Akers Biosciences Announces $4.8M Registered Direct Offering
Post on 5/17/20
-
Onconova Therapeutics Provides Corporate Update
Post on 5/17/20
-
Oyster Point Pharma Proposed Public Offering of Common Stock
Post on 5/17/20